Patrick John Jermain Sells 2,321 Shares of Plexus (NASDAQ:PLXS) Stock

Plexus Corp. (NASDAQ:PLXS) CFO Patrick John Jermain sold 2,321 shares of the firm’s stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $201.12, for a total transaction of $466,799.52. Following the completion of the transaction, the chief financial officer directly owned 14,561 shares of the company’s stock, valued at approximately $2,928,508.32. This represents a 13.75% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Patrick John Jermain also recently made the following trade(s):

• On Wednesday, February 4th, Patrick John Jermain sold 3,587 shares of Plexus stock. The shares were sold at an average price of $204.09, for a total value of $732,070.83.
• On Tuesday, February 3rd, Patrick John Jermain sold 4,841 shares of Plexus stock. The shares were sold at an average price of $204.01, for a total value of $987,612.41.

Plexus Stock Performance

Shares of Plexus stock traded down $5.33 on Tuesday, reaching $195.95. 392,145 shares of the stock were exchanged, compared to its average volume of 361,627. The business has a 50 day moving average price of $172.63 and a two-hundred day moving average price of $151.68. The firm has a market capitalization of $5.25 billion, a price-to-earnings ratio of 30.47 and a beta of 0.81. Plexus Corp. has a twelve month low of $103.43 and a twelve month high of $211.84. The company has a quick ratio of 0.75, a current ratio of 1.59 and a debt-to-equity ratio of 0.06.

Plexus (NASDAQ:PLXS) last released its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 earnings per share for the quarter, topping analysts’ consensus estimates of $1.77 by $0.01. The firm had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.07 billion. Plexus had a net margin of 4.28% and a return on equity of 12.39%. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.73 earnings per share. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. Analysts anticipate that Plexus Corp. will post 5.9 earnings per share for the current fiscal year.

Institutional Trading of Plexus

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Amundi increased its position in shares of Plexus by 68.1% during the fourth quarter. Amundi now owns 12,876 shares of the technology company’s stock valued at $1,893,000 after acquiring an additional 5,218 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in Plexus by 2.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 25,554 shares of the technology company’s stock valued at $3,757,000 after purchasing an additional 731 shares during the last quarter. Watershed Asset Management L.L.C. purchased a new stake in Plexus in the fourth quarter valued at approximately $418,000. Osaic Holdings Inc. lifted its stake in Plexus by 25.0% during the fourth quarter. Osaic Holdings Inc. now owns 3,884 shares of the technology company’s stock worth $571,000 after purchasing an additional 777 shares in the last quarter. Finally, California State Teachers Retirement System boosted its position in shares of Plexus by 2.1% during the fourth quarter. California State Teachers Retirement System now owns 25,665 shares of the technology company’s stock worth $3,773,000 after buying an additional 519 shares during the period. 94.45% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

PLXS has been the subject of a number of analyst reports. Zacks Research upgraded shares of Plexus from a “hold” rating to a “strong-buy” rating in a research report on Friday, February 6th. Wall Street Zen cut Plexus from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. Sidoti lowered Plexus from a “buy” rating to a “neutral” rating and set a $150.00 target price on the stock. in a research report on Friday, October 24th. Weiss Ratings raised shares of Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, February 5th. Finally, Needham & Company LLC lifted their target price on shares of Plexus from $165.00 to $206.00 and gave the company a “buy” rating in a research report on Friday, January 30th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $189.20.

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.